Research in Stevens-Johnson syndrome/toxic epidermal necrolysis (TEN): a network of specialist TEN centres is needed to undertake effective clinical studies and therapeutic trials
Br J Dermatol
.
2013 Dec;169(6):1177.
doi: 10.1111/bjd.12710.
Authors
D Creamer
1
,
S Walsh
Affiliation
1
Department of Dermatology, King's College Hospital, London, U.K.. daniel.creamer@nhs.net.
PMID:
24299527
DOI:
10.1111/bjd.12710
No abstract available
Publication types
Comment
MeSH terms
Female
Humans
Immunoglobulins, Intravenous / therapeutic use*
Immunologic Factors / therapeutic use*
Male
Stevens-Johnson Syndrome / drug therapy*
Substances
Immunoglobulins, Intravenous
Immunologic Factors